The glioma-associated antigen interleukin-13 receptor alpha 2 (IL13Rα2), found in approximately 58% of adult GBM cases and 83% of pediatric brain tumors, has also been targeted by CAR-T cells in the clinical setting [63, 64]. Here, IL13RA2 is linked to glioblastoma.